Agenus Inc.

NasdaqCM:AGEN 株式レポート

時価総額：US$111.5m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Agenus マネジメント

マネジメント 基準チェック /24

Agenus'の CEO はGaro Armenで、 Jan1994年に任命され、 の在任期間は 30.42年です。 の年間総報酬は$ 5.86Mで、 12.1%給与と87.9%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.64%を直接所有しており、その価値は$ 2.07M 。経営陣と取締役会の平均在任期間はそれぞれ2.4年と5.9年です。

主要情報

Garo Armen

最高経営責任者

US$5.9m

報酬総額

CEO給与比率12.1%
CEO在任期間30.7yrs
CEOの所有権0.7%
経営陣の平均在職期間2.7yrs
取締役会の平均在任期間3.9yrs

経営陣の近況

Recent updates

Agenus: Novel Drugs That Just Are Not Novel

Jul 24

There's No Escaping Agenus Inc.'s (NASDAQ:AGEN) Muted Revenues Despite A 102% Share Price Rise

May 21
There's No Escaping Agenus Inc.'s (NASDAQ:AGEN) Muted Revenues Despite A 102% Share Price Rise

Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results

May 09
Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results

Benign Growth For Agenus Inc. (NASDAQ:AGEN) Underpins Stock's 25% Plummet

Mar 29
Benign Growth For Agenus Inc. (NASDAQ:AGEN) Underpins Stock's 25% Plummet

Agenus: 2024 May Finally Be The Year For A Major Turnaround

Jan 18

Improved Revenues Required Before Agenus Inc. (NASDAQ:AGEN) Shares Find Their Feet

Dec 22
Improved Revenues Required Before Agenus Inc. (NASDAQ:AGEN) Shares Find Their Feet

News Flash: Analysts Just Made A Huge Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts

Nov 09
News Flash: Analysts Just Made A Huge Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts

A Look At The Fair Value Of Agenus Inc. (NASDAQ:AGEN)

Oct 04
A Look At The Fair Value Of Agenus Inc. (NASDAQ:AGEN)

Industry Analysts Just Made A Notable Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Revenue Forecasts

May 10
Industry Analysts Just Made A Notable Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Revenue Forecasts

VBI Vaccines, Agenus to examine VBI-1901 + balstilimab combo for glioblastoma

Oct 12

Agenus New Trials Set It Up For The Long Haul

Sep 27

Agenus: It's Always Tomorrow

Sep 16

Agenus GAAP EPS of -$0.17, revenue of $20.93M

Aug 09

Agenus: Successfully Pulled Itself Away From Disaster

Jul 04

Agenus: Not Quite Enough

Apr 19

Auditors Have Doubts About Agenus (NASDAQ:AGEN)

Mar 06
Auditors Have Doubts About Agenus (NASDAQ:AGEN)

Agenus: Making Another Effort With The FDA

Jan 25

Agenus Inc.'s Imminent 1181/Bal Data Release And MiNK IPO Should Lead To Enormous Valuation Gains

Aug 25

Agenus Multiple Value-Adding Events Ahead

Aug 18

Party Time: Brokers Just Made Major Increases To Their Agenus Inc. (NASDAQ:AGEN) Earnings Forecasts

Aug 11
Party Time: Brokers Just Made Major Increases To Their Agenus Inc. (NASDAQ:AGEN) Earnings Forecasts

CEO報酬分析

Agenus の収益と比較して、Garo Armen の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$224m

Mar 31 2024n/an/a

-US$240m

Dec 31 2023US$6mUS$710k

-US$246m

Sep 30 2023n/an/a

-US$271m

Jun 30 2023n/an/a

-US$263m

Mar 31 2023n/an/a

-US$240m

Dec 31 2022US$6mUS$689k

-US$220m

Sep 30 2022n/an/a

-US$215m

Jun 30 2022n/an/a

US$18m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021US$10mUS$655k

-US$24m

Sep 30 2021n/an/a

US$4m

Jun 30 2021n/an/a

-US$226m

Mar 31 2021n/an/a

-US$190m

Dec 31 2020US$6mUS$677k

-US$181m

Sep 30 2020n/an/a

-US$174m

Jun 30 2020n/an/a

-US$168m

Mar 31 2020n/an/a

-US$171m

Dec 31 2019US$10mUS$634k

-US$108m

Sep 30 2019n/an/a

-US$126m

Jun 30 2019n/an/a

-US$113m

Mar 31 2019n/an/a

-US$87m

Dec 31 2018US$3mUS$610k

-US$160m

Sep 30 2018n/an/a

-US$147m

Jun 30 2018n/an/a

-US$151m

Mar 31 2018n/an/a

-US$158m

Dec 31 2017US$4mUS$593k

-US$121m

報酬と市場: Garoの 総報酬 ($USD 5.86M ) は、 US市場 ($USD 2.45M ) の同規模の企業の平均を上回っています。

報酬と収益: Garoの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Garo Armen (71 yo)

30.7yrs

在職期間

US$5,856,319

報酬

Dr. Garo H. Armen, Ph.D. founded Agenus Inc. in 1994 and has been Chief Executive Officer since 1994. He serves as an Executive Chairman at MiNK Therapeutics, Inc. Dr. Armen serves as an Executive Chairman...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Garo Armen
Founder30.7yrsUS$5.86m0.70%
$ 785.2k
Christine Klaskin
VP of Finance17.9yrsUS$712.75k0.036%
$ 39.8k
Steven O'Day
Chief Medical Officer3.7yrsUS$1.44m0.063%
$ 70.4k
Craig Winter
Chief Information Officer2.7yrsデータなしデータなし
Zack Armen
Head of Investor Relationsno dataデータなしデータなし
Tracy Clemente
Chief People Officer2.7yrsデータなしデータなし
Alfred Dadson
Chief Manufacturing Officerno dataデータなしデータなし
Eric Humes
Chief Quality Officer2.7yrsデータなしデータなし
Todd Yancey
Member of Advisory Board & Chief Strategic Advisorless than a yearデータなしデータなし
Robin Taylor
Chief Commercial Officer1.2yrsデータなしデータなし
Nils Eckardt
Chief Medical Affairs Officerless than a yearデータなしデータなし
Jennifer Buell
Director and President & CEO of MiNK Therapeutics2.7yrsUS$7.42m0.063%
$ 70.7k

2.7yrs

平均在職期間

60.5yo

平均年齢

経験豊富な経営陣: AGENの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Garo Armen
Founder25.7yrsUS$5.86m0.70%
$ 785.2k
Todd Yancey
Member of Advisory Board & Chief Strategic Advisor1.7yrsデータなしデータなし
Jennifer Buell
Director and President & CEO of MiNK Therapeuticsless than a yearUS$7.42m0.063%
$ 70.7k
Robert Stein
Member of Advisory Board1.7yrsUS$1.04mデータなし
Ulf Wiinberg
Independent Director8.3yrsUS$366.39k0.029%
$ 32.1k
Timothy Wright
Independent Lead Director17.8yrsUS$385.50k0.013%
$ 14.3k
Larry Norton
Member of Advisory Board1.7yrsデータなしデータなし
Brian Corvese
Independent Director17.5yrsUS$888.14k0.021%
$ 23.8k
Susan Hirsch
Independent Director3.9yrsUS$242.00k0.028%
$ 30.7k

3.9yrs

平均在職期間

68.5yo

平均年齢

経験豊富なボード: AGENの 取締役会 は 経験豊富 であると考えられます ( 5.9年の平均在任期間)。